MoonLake Immunotherapeutics MLTX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 7.17 | 106.02 | -1.10 | -71,433 | -71 | |
| 2025Q2 | 47.20 | 112.57 | -0.87 | -60,698 | -56 | |
| 2025Q1 | 39.07 | 117.57 | -0.63 | -47,485 | -41 | |
| 2024Q4 | 54.15 | 106.96 | -0.72 | -49,580 | -46 | |
| 2024Q3 | 50.42 | 119.68 | -0.57 | -43,112 | -36 | |
| 2024Q2 | 43.97 | 123.90 | -0.38 | -30,579 | -25 | |
| 2024Q1 | 50.23 | 142.54 | -0.22 | -19,820 | -14 | |
| 2023Q4 | 60.39 | 191.62 | -0.10 | -15,029 | -8 | |
| 2023Q3 | 57.00 | 111.96 | -0.17 | -12,977 | -12 | |
| 2023Q2 | 51.00 | 106.83 | -0.23 | -13,186 | -12 | |
| 2023Q1 | 21.39 | 105.93 | -0.23 | -12,932 | -12 | |
| 2022Q4 | 10.50 | 101.46 | -0.43 | -16,696 | -16 | |
| 2022Q3 | 7.76 | 100.26 | -0.14 | -14,771 | -15 | |
| 2022Q2 | 5.25 | 101.41 | 2.04 | -17,652 | -17 | |
| 2022Q1 | 100.30 | -3.17 | -2,711 | -3 | ||
| 2021Q4 | 99.84 | 3.44 | 34,729 | 35 | ||
| 2021Q3 | 99.90 | -1.95 | 30,686 | 31 | ||
| 2021Q2 | 103.95 | -2.09 | -158 | 0 | ||
| 2021Q1 | 123.68 | -0.02 | -94 | 0 |